Neuros Medical just raised. Here's exactly what to do next.
Who to reach, what to say, and why now — on Neuros Medical, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Everyone else gives you a piece
Only Fundz delivers all four.
Neuros Medical raises $56M in Series D funding led by EQT Life Sciences to commercialize the Altius® System for chronic post-amputation pain.
Amount Raised
$56 Million
Round Type
series d
Investors
Description
Neuros Medical, Inc. has closed a $56 million Series D financing round to support the commercialization of its Altius® Direct Electrical Nerve Stimulation System. The round was led by EQT Life Sciences, with participation from US Venture Partners and others. This funding validates the medical need within the amputee community
Related People
Funding Insights
Based on industry dataWatching Neuros Medical? See every signal — funding, hires, M&A, contracts, sentiment.
Request a demoChoose your plan